Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Neo-adjuvant therapy and surgical decision making in breast cancer

Dr Mehra Golshan - Yale School of Medicine, New Haven, USA
Neo-adjuvant therapy and surgical decision making in breast cancer ( Dr Mehra Golshan - Yale School of Medicine, New Haven, USA )
17 Feb 2021

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK
Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )
17 Feb 2021

ITACA NSCLC study: Final results

Prof Silvia Novello - University of Turin, Turin, Italy
ITACA NSCLC study: Final results ( Prof Silvia Novello - University of Turin, Turin, Italy )
16 Feb 2021

Renal liposarcoma: Case report and review of systemic treatment

Dr Abel Centurion - Peruvian National Cancer Institute, Surquillo, Peru
Renal liposarcoma: Case report and review of systemic treatment ( Dr Abel Centurion -  Peruvian National Cancer Institute, Surquillo, Peru )
16 Feb 2021

Updates on managing HER2-positive early breast cancer

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain
Updates on managing HER2-positive early breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )
16 Feb 2021

Managing HER2-positive breast cancer

Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA
Managing HER2-positive breast cancer ( Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )
16 Feb 2021

Management of axilla after neo-adjuvant treatment

Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA
Management of axilla after neo-adjuvant treatment ( Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )
16 Feb 2021

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC

Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC ( Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia )
16 Feb 2021

TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
15 Feb 2021

ASCO GU 2021: Renal cancer roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2021: Renal cancer roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
15 Feb 2021

OncoAlert and ecancer weekly roundup for February 07 - 13, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
15 Feb 2021

COVID-19 pandemic threatens global life-saving gains in childhood cancer

Prof Kathy Pritchard-Jones - University College London, London, UK
COVID-19 pandemic threatens global life-saving gains in childhood cancer ( Prof Kathy Pritchard-Jones - University College London, London, UK )
12 Feb 2021